« Back
Home /
Ramucirumab

Ramucirumab

Item no.	TMO-T9929-1mg
Manufacturer	TargetMol
CASRN	947687-13-0
Amount	1 mg
Quantity options	10 mg 1 mg 25mg 50mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	Fala L. Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer. Am Health Drug Benefits. 2015 Mar;8(Spec Feature):49-53.
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	947687-13-0
Shipping condition	Cool pack
Available
Manufacturer - Targets	VEGFR
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	147 kDa
Description	Ramucirumab, a human VEGFR-2 antagonist, is used for the treatment of solid tumors.
Pathways	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T9929-1mg-datasheet.pdf

TMO-T9929-1mg-safety-datasheet.pdf